` 600641 (Shanghai Wanye Enterprises Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

S
600641
vs
S
Shanghai Composite

Over the past 12 months, Shanghai Wanye Enterprises Co Ltd has underperformed Shanghai Composite, delivering a return of +11% compared to the Shanghai Composite's +25% growth.

Stocks Performance
600641 vs Shanghai Composite

Loading
600641
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600641 vs Shanghai Composite

Performance Gap Between 600641 and SSEC
HIDDEN
Show

Performance By Year
600641 vs Shanghai Composite

Loading
600641
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Shanghai Wanye Enterprises Co Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shanghai Wanye Enterprises Co Ltd
Glance View

Market Cap
15.9B CNY
Industry
Real Estate

Shanghai Wanye Enterprises Co Ltd has traversed an intriguing journey from its origins, evolving into a dynamic player in several sectors. Rooted in the bustling metropolis of Shanghai, the company navigates multiple industries with a focus on real estate, biotechnology, and high-tech investments. Over the years, Wanye has astutely recognized the potential in blending traditional real estate ventures with new-age biotech innovations. Its real estate arm concentrates primarily on the development and management of commercial and residential properties, leveraging its deep understanding of urban landscapes to maximize asset value. Meanwhile, its interest in biotechnology represents a strategic pivot towards high-growth sectors, signifying an alignment with global trends in health and science innovations. Money-making for Wanye Enterprises involves a sophisticated balance of developing high-demand real estate projects and acquiring stakes in promising biotech start-ups and technological ventures. This dual approach not only diversifies its revenue streams but also mitigates risks associated with market fluctuations in single sectors. The company's real estate segment generates consistent cash flow through property sales and rental income, underwriting its forays into the less predictable biotech sector. Meanwhile, investments in technology and biotechnology hold the potential for substantial returns, underpinning growth through innovations that could revolutionize industries. Through strategic investment, development expertise, and market adaptability, Shanghai Wanye Enterprises Co Ltd effectively harnesses various economic waves, positioning itself as a resilient business entity in China's rapidly evolving economic landscape.

Shanghai Wanye Enterprises Co Ltd Intrinsic Value
HIDDEN
Show
Back to Top